BioTissue Ocular

We’re heading to !

BioTissue is excited to connect with the Optometric community and showcase innovations that help support better healing and patient outcomes.¹⁻² Stop by Booth #405 to learn more about our solutions and how we’re advancing ocular surface care.

See you there!



1. Data on File.

2. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918. https://brnw.ch/21x3ctb

BioTissue’s ocular portfolio leverages Cryopreserved Amniotic Membrane across a range of clinical applications to support ocular surface healing, reduce dry eye signs and symptoms, and enhance patient outcomes.¹⁻²



1. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918. https://brnw.ch/21x32sB

2. McDonald, M, Janik, SB, Bowden, FW. et al. Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane. Clin Ophthalmol. 2023;Sep 12:17:2697- 2703. https://brnw.ch/21x32sC

We’re heading back to Kiawah Eye.

Don’t miss the chance to hear from our President & CEO, Ted Davis, who will be presenting on the Innovation Panel during the meeting.

Stop by to meet our team, and ask questions around Cryopreserved Amniotic Membrane for your patients. We’re here to share insights and help you find the right approach for ocular surface care.

Early intervention may help change the course of ocular surface disease.

BioTissue’s Cryopreserved Amniotic Membrane (CAM) exerts anti-inflammatory, anti-scarring, and anti-angiogenic actions to promote wound healing.¹

Explore CAM360 AmnioGraft, a CAM in-office therapy for managing mild–moderate cases.

Download the quick guide: https://brnw.ch/21x2DDQ

*Please refer to our Product Insert for storage information

1. Data on file.

PECAA + BioTissue = better together 🤝

We’re heading to San Diego next week and bringing our team with us. Look out for these faces, we are here to help you make the most of your PECAA partnership.

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-on wet lab experience with Cryopreserved Amniotic Membrane, it was all about showing how CAM360 AmnioGraft™, Prokera® Slim, and Prokera® Clear, can fit into your practice.

Take full advantage of your Vision Source partnership. Connect with our team: https://biotissue.com/contact-us/

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-on wet lab experience with Cryopreserved Amniotic Membrane, it was all about showing how CAM360 AmnioGraft™, Prokera® Slim, and Prokera® Clear, can fit into your practice.

Take full advantage of your Vision Source partnership. Connect with our team: https://brnw.ch/21x2i3v

Great conversations at Intrepid Eye.

Our VP of Marketing, Tiffany Matthews, joined the panel on influencing OD behavior, highlighting an important shift: interventional treatments can play a bigger role in how optometry approaches ocular surface disease.

We also had the opportunity to hear directly from an advisory board, with valuable insights that continue to shape how we support the optometric community.

Thank you to Intrepid Eye for bringing together such meaningful conversations.